How many clinical trials have tested Efamol products and how does this help guarantee the quality/efficacy of those product?
For the last three decades, Efamol has been committed to testing the efficacy of its products in human clinical trials to confirm they work for their intended use. Efamol has been responsible for most of the published scientific studies confirming the health benefits of EPO and GLA. A GLA bibliography published in 1996 included approximately 750 publications pertaining to GLA derived from Efamol® EPO with nearly half of those being clinical trials. Many other companies base their product claims and recommendations for their EPO and other GLA containing oils on work carried out by Efamol or independent researchers using Efamol® EPO as the source of GLA. These claims are unfounded. Efamol® EPO is extracted from unique seed varieties using a special technique that creates distinctive oil. Therefore, oils otherwise manufactured may not match the efficacy of Efamol® EPO. In addition to the work carried out on Efamol® EPO, there have been nine clinical studies reporting the benefits of Efale
